Scientific Presentations at 2019 Ruesch Symposium Inspire
December 10th, 2019
The 10th Annual Ruesch Symposium provided a forum for discussions on cutting-edge research and the pipeline of promising new therapies and technologies in GI cancers.
10th Annual Ruesch Symposium
Learn more about this year’s topics, speakers, agenda and register today
More information
New Colon Cancer Concerns
Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
Patient & Families
Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.
Current Clinical Trials
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Does the tumor microbiome play a role in early-onset colorectal cancer?
October 30th, 2019
The human body is composed of around a trillion cells, and there are a trillion to a trillion-and-a-half bacterial cells composing our gut microbiome. Of these bacteria, some are good and help us digest foods. Others can behave badly and are associated with diseases such as autoimmunity and cancer.
The Quest for a Cure: Cancer Expert John Marshall ’79 on Battling the Disease in His Work and His Family
October 25th, 2019
Dr. John Marshall was recently the keynote “Faces of Cancer” event at his alma mater, the Episcopal High School in Alexandria VA. He shared his personal experiences with cancer and discussed myths about the disease, the economics of treatment, and his work to advance genetics-driven precision medicine.
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.